Enhanced Transepithelial Riboflavin Delivery Across the Cornea Using Magnetic Nanocarriers.

IF 1.9 4区 医学 Q2 OPHTHALMOLOGY
Alaaddin Coskun, Fatih Senturk, Eylem Turan
{"title":"Enhanced Transepithelial Riboflavin Delivery Across the Cornea Using Magnetic Nanocarriers.","authors":"Alaaddin Coskun, Fatih Senturk, Eylem Turan","doi":"10.1089/jop.2024.0183","DOIUrl":null,"url":null,"abstract":"<p><p><b><i>Purpose:</i></b> Keratoconus is a progressive corneal ectasia characterized by irregular astigmatism, leading to corneal scarring and decreased vision. Corneal cross-linking (CXL) is the standard treatment to halt disease progression, but its effectiveness in transepithelial (epithelium-on, epi-on) approaches is limited by the low permeability of the corneal epithelium to riboflavin (Rb). This study aimed to enhance transepithelial Rb penetration in <i>ex vivo</i> bovine corneas using Rb-modified tannic acid-coated superparamagnetic iron oxide nanoparticles (Rb-TA-SPIONs) under an external magnetic field. <b><i>Methods:</i></b> SPIONs were synthesized via co-precipitation, modified with TA and Rb, and characterized by physicochemical techniques. The average size of the Rb-TA-SPIONs was 46 ± 5.3 nm, with a saturation magnetization of 55.9 emu/g. <i>Ex vivo</i> experiments involved the application of 0.1% Rb to bovine corneas, and penetration was evaluated under epi-on conditions with iontophoresis (1-5 mA, 5 min). In addition, a 0.1% Rb-containing nanocarrier solution was tested under magnetic fields of 1-300 Gauss. <b><i>Results:</i></b> Results showed increased Rb penetration with rising electric current density and Rb-TA-SPION penetration with stronger magnetic fields, compared with epi-on control groups. Specifically, Rb penetration increased from 0.036% (<i>P</i> ≤ 0.01) at 1 mA to 0.059% (<i>P</i> ≤ 0.001) at 5 mA in the iontophoresis group and from 0.035% (<i>P</i> ≤ 0.001) at 1 G to 0.054% (<i>P</i> ≤ 0.001) at 300 G in the magnetic group. <b><i>Conclusion:</i></b> These findings indicate that magnetic nanoparticle-assisted Rb delivery, guided by an external magnetic field, could improve potential CXL efficacy by enhancing Rb penetration and corneal permeability.</p>","PeriodicalId":16689,"journal":{"name":"Journal of Ocular Pharmacology and Therapeutics","volume":" ","pages":"131-140"},"PeriodicalIF":1.9000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Ocular Pharmacology and Therapeutics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1089/jop.2024.0183","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/30 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: Keratoconus is a progressive corneal ectasia characterized by irregular astigmatism, leading to corneal scarring and decreased vision. Corneal cross-linking (CXL) is the standard treatment to halt disease progression, but its effectiveness in transepithelial (epithelium-on, epi-on) approaches is limited by the low permeability of the corneal epithelium to riboflavin (Rb). This study aimed to enhance transepithelial Rb penetration in ex vivo bovine corneas using Rb-modified tannic acid-coated superparamagnetic iron oxide nanoparticles (Rb-TA-SPIONs) under an external magnetic field. Methods: SPIONs were synthesized via co-precipitation, modified with TA and Rb, and characterized by physicochemical techniques. The average size of the Rb-TA-SPIONs was 46 ± 5.3 nm, with a saturation magnetization of 55.9 emu/g. Ex vivo experiments involved the application of 0.1% Rb to bovine corneas, and penetration was evaluated under epi-on conditions with iontophoresis (1-5 mA, 5 min). In addition, a 0.1% Rb-containing nanocarrier solution was tested under magnetic fields of 1-300 Gauss. Results: Results showed increased Rb penetration with rising electric current density and Rb-TA-SPION penetration with stronger magnetic fields, compared with epi-on control groups. Specifically, Rb penetration increased from 0.036% (P ≤ 0.01) at 1 mA to 0.059% (P ≤ 0.001) at 5 mA in the iontophoresis group and from 0.035% (P ≤ 0.001) at 1 G to 0.054% (P ≤ 0.001) at 300 G in the magnetic group. Conclusion: These findings indicate that magnetic nanoparticle-assisted Rb delivery, guided by an external magnetic field, could improve potential CXL efficacy by enhancing Rb penetration and corneal permeability.

利用磁性纳米载体增强角膜上皮核黄素的传递。
目的:圆锥角膜是一种以不规则散光为特征的进行性角膜扩张,导致角膜瘢痕形成和视力下降。角膜交联(CXL)是阻止疾病进展的标准治疗方法,但其经上皮(上皮-on, epi-on)方法的有效性受到角膜上皮对核黄素(Rb)的低通透性的限制。本研究旨在利用Rb修饰的单宁酸包覆的超顺磁性氧化铁纳米颗粒(Rb- ta - spions)在外加磁场作用下增强Rb在离体牛角膜上皮的穿透性。方法:采用共沉淀法合成SPIONs,用TA和Rb进行改性,并用理化方法对其进行表征。Rb-TA-SPIONs的平均尺寸为46±5.3 nm,饱和磁化强度为55.9 emu/g。离体实验包括将0.1%的Rb应用于牛角膜,并在离子透入条件下(1-5 mA, 5 min)评估透入性。此外,在1-300高斯的磁场下,对0.1%含铷纳米载体溶液进行了测试。结果:与epi-on对照组相比,Rb穿透率随电流密度的增加而增加,Rb- ta - spion穿透率随磁场的增强而增加。其中,离子透入组Rb穿透率从1 mA时的0.036% (P≤0.01)增加到5 mA时的0.059% (P≤0.001),磁性组从1 G时的0.035% (P≤0.001)增加到300 G时的0.054% (P≤0.001)。结论:在外加磁场的引导下,磁性纳米粒子辅助Rb递送可通过增强Rb的穿透性和角膜通透性来提高CXL的潜在疗效。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
4.60
自引率
4.30%
发文量
72
审稿时长
1 months
期刊介绍: Journal of Ocular Pharmacology and Therapeutics is the only peer-reviewed journal that combines the fields of ophthalmology and pharmacology to enable optimal treatment and prevention of ocular diseases and disorders. The Journal delivers the latest discoveries in the pharmacokinetics and pharmacodynamics of therapeutics for the treatment of ophthalmic disorders. Journal of Ocular Pharmacology and Therapeutics coverage includes: Glaucoma Cataracts Retinal degeneration Ocular infection, trauma, and toxicology Ocular drug delivery and biotransformation Ocular pharmacotherapy/clinical trials Ocular inflammatory and immune disorders Gene and cell-based therapies Ocular metabolic disorders Ocular ischemia and blood flow Proliferative disorders of the eye Eyes on Drug Discovery - written by Gary D. Novack, PhD, featuring the latest updates on drug and device pipeline developments as well as policy/regulatory changes by the FDA.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信